Angela James currently serves as Vice President of Clinical Development at iTeos Therapeutics, a position held since July 2023. Prior experience includes serving as Vice President and Head of Clinical Pharmacology at MacroGenics, Inc. from June 2021 to June 2023, and at Astellas Pharma US as Director overseeing Global Development Projects and Clinical Pharmacology in Oncology from May 2015 to June 2021. Angela's career began at Celgene as Associate Director and Senior Scientist, followed by a Senior Scientist III role at Alcon Laboratories, Inc. Academic qualifications include a Doctor of Philosophy in Pharmaceutical Sciences and a Master of Science in Pharmacometrics from the University of Maryland Baltimore, a Master of Science in Pharmaceutical Sciences from the University of Houston, and a Bachelor of Arts in Biology from Rice University.